The role of FDG-PET in the interim evaluation of therapy response in diffuse large B-cell lymphoma

被引:0
|
作者
Ellmann, Annare [1 ,2 ]
机构
[1] Univ Stellenbosch, Cape Town, South Africa
[2] Tygerberg Hosp, Cape Town, South Africa
关键词
POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; INTERNATIONAL HARMONIZATION PROJECT; SUV-BASED ASSESSMENT; PROGNOSTIC VALUE; F-18-FDG PET; MALIGNANT-LYMPHOMA; CHEMOTHERAPY; SCANS; FLUORODEOXYGLUCOSE;
D O I
10.1016/j.transci.2013.05.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The significance of FDG PET in the interim follow-up of patients with diffuse large B-cell lymphoma to evaluate therapy response is currently being debated. Reports with discordant results have been published. Several authors have reported a low positive predictive value when using FDG PET to evaluate interim therapy response. Different criteria for the interpretation of PET studies in these patients are available, producing variable results. The latest publications and the review criteria will be summarised in this paper. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:40 / 42
页数:3
相关论文
共 50 条
  • [21] The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
    Hoppe, B. S.
    Moskowitz, C. H.
    Zhang, Z.
    Maragulia, J. C.
    Rice, R. D.
    Reiner, A. S.
    Hamlin, P. A.
    Zelenetz, A. D.
    Yahalom, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 (12) : 941 - 948
  • [22] Reply: Interim FDG-PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure?
    Lazarovici, Julien
    Terroir-Cassou-Mounat, Marie
    Ghez, David
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (05) : 884 - 885
  • [23] The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
    B S Hoppe
    C H Moskowitz
    Z Zhang
    J C Maragulia
    R D Rice
    A S Reiner
    P A Hamlin
    A D Zelenetz
    J Yahalom
    Bone Marrow Transplantation, 2009, 43 : 941 - 948
  • [24] FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview
    Voltin, Conrad-Amadeus
    Mettler, Jasmin
    Grosse, Jirka
    Dietlein, Markus
    Baues, Christian
    Schmitz, Christine
    Borchmann, Peter
    Kobe, Carsten
    Hellwig, Dirk
    CANCERS, 2020, 12 (03)
  • [25] Treatment Assessment Using FDG-PET for Primary Diffuse Large B-Cell Lymphoma of the Bone
    Harada, A.
    Oguchi, M.
    Ookubo, H.
    Taguchi, S.
    Terui, Y.
    Hatake, K.
    Takeuchi, K.
    Ae, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E428 - E429
  • [26] FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma
    Mashriqi, Faizullah
    Keir, Graham
    Glaser, Joseph E.
    Franceschi, Ana M.
    Vijayashanka, Akarsh
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2024, 23 (02) : 126 - 129
  • [27] Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma
    Adams, Hugo J. A.
    de Klerk, John M. H.
    Fijnheer, Rob
    Heggelman, Ben G. F.
    Dubois, Stefan V.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (01) : 304 - 309
  • [28] Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: Emerging Worldwide?
    Jamar, Francois
    Lhommel, Renaud
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) : 655 - 656
  • [29] Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
    Czibor, Sandor
    Carr, Robert
    Redondo, Francisca
    Auewarakul, Chirayu U.
    Cerci, Juliano J.
    Paez, Diana
    Fanti, Stefano
    Gyorke, Tamas
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (04) : 291 - 301
  • [30] Predictive Value of Interim FDG-PET/CT Interpreted withDeauville 5-point Score in Diffuse Large B-cell Lymphoma
    Zhang, Xu
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59